407 related articles for article (PubMed ID: 24966611)
1. Recurrent Clostridium difficile infections: the importance of the intestinal microbiota.
Zanella Terrier MC; Simonet ML; Bichard P; Frossard JL
World J Gastroenterol; 2014 Jun; 20(23):7416-23. PubMed ID: 24966611
[TBL] [Abstract][Full Text] [Related]
2. The role of the gut microbiome in colonization resistance and recurrent
Seekatz AM; Safdar N; Khanna S
Therap Adv Gastroenterol; 2022; 15():17562848221134396. PubMed ID: 36425405
[TBL] [Abstract][Full Text] [Related]
3. Fecal Microbiota Transplantation and Medical Therapy for Clostridium difficile Infection : Meta-analysis of Randomized Controlled Trials.
Singh T; Bedi P; Bumrah K; Gandhi D; Arora T; Verma N; Schleicher M; Rai MP; Garg R; Verma B; Sanaka MR
J Clin Gastroenterol; 2022 Nov-Dec 01; 56(10):881-888. PubMed ID: 34516460
[TBL] [Abstract][Full Text] [Related]
4. Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention.
Lavoie T; Appaneal HJ; LaPlante KL
Clin Infect Dis; 2023 Dec; 77(Suppl 6):S447-S454. PubMed ID: 38051964
[TBL] [Abstract][Full Text] [Related]
5. Navigating changes in
Durham SH; Le P; Cassano AT
J Manag Care Spec Pharm; 2020 Dec; 26(12-a Suppl):S3-S23. PubMed ID: 33533699
[No Abstract] [Full Text] [Related]
6. Humanized microbiota mice as a model of recurrent Clostridium difficile disease.
Collins J; Auchtung JM; Schaefer L; Eaton KA; Britton RA
Microbiome; 2015 Aug; 3():35. PubMed ID: 26289776
[TBL] [Abstract][Full Text] [Related]
7. The potential of microbiome replacement therapies for Clostridium difficile infection.
Buckley AM; Moura IB; Wilcox MH
Curr Opin Gastroenterol; 2022 Jan; 38(1):1-6. PubMed ID: 34871192
[TBL] [Abstract][Full Text] [Related]
8. Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.
Kelly CR; Kahn S; Kashyap P; Laine L; Rubin D; Atreja A; Moore T; Wu G
Gastroenterology; 2015 Jul; 149(1):223-37. PubMed ID: 25982290
[TBL] [Abstract][Full Text] [Related]
9. Clostridium Difficile Infection from a Surgical Perspective.
Kaiser AM; Hogen R; Bordeianou L; Alavi K; Wise PE; Sudan R;
J Gastrointest Surg; 2015 Jul; 19(7):1363-77. PubMed ID: 25917533
[TBL] [Abstract][Full Text] [Related]
10. Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study.
Langdon A; Schwartz DJ; Bulow C; Sun X; Hink T; Reske KA; Jones C; Burnham CD; Dubberke ER; Dantas G;
Genome Med; 2021 Feb; 13(1):28. PubMed ID: 33593430
[TBL] [Abstract][Full Text] [Related]
11. The microbiota and immune response during Clostridium difficile infection.
Buonomo EL; Petri WA
Anaerobe; 2016 Oct; 41():79-84. PubMed ID: 27212111
[TBL] [Abstract][Full Text] [Related]
12. Review Article: Gastroenterology and Clostridium difficile Infection: Past, Present, and Future.
Kelly CR; Allegretti JR
Clin Infect Dis; 2023 Dec; 77(Suppl 6):S463-S470. PubMed ID: 38051967
[TBL] [Abstract][Full Text] [Related]
13. Probiotics for prevention of Clostridium difficile infection.
Mills JP; Rao K; Young VB
Curr Opin Gastroenterol; 2018 Jan; 34(1):3-10. PubMed ID: 29189354
[TBL] [Abstract][Full Text] [Related]
14. BaiCD gene cluster abundance is negatively correlated with Clostridium difficile infection.
Solbach P; Chhatwal P; Woltemate S; Tacconelli E; Buhl M; Gerhard M; Thoeringer CK; Vehreschild MJGT; Jazmati N; Rupp J; Manns MP; Bachmann O; Suerbaum S
PLoS One; 2018; 13(5):e0196977. PubMed ID: 29738579
[TBL] [Abstract][Full Text] [Related]
15. Fecal Microbiota Transplantation: Redefining Surgical Management of Refractory
Cheng YW; Fischer M
Clin Colon Rectal Surg; 2020 Mar; 33(2):92-97. PubMed ID: 32104162
[TBL] [Abstract][Full Text] [Related]
16. Fecal transplantation for the treatment of recurrent clostridium difficile infection.
Karadsheh Z; Sule S
N Am J Med Sci; 2013 Jun; 5(6):339-43. PubMed ID: 23923106
[TBL] [Abstract][Full Text] [Related]
17. Clostridioides difficile infections; new treatments and future perspectives.
Normington C; Chilton CH; Buckley AM
Curr Opin Gastroenterol; 2024 Jan; 40(1):7-13. PubMed ID: 37942659
[TBL] [Abstract][Full Text] [Related]
18. Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent
Stallhofer J; Steube A; Katzer K; Stallmach A
Visc Med; 2024 Apr; 40(2):82-91. PubMed ID: 38584858
[TBL] [Abstract][Full Text] [Related]
19.
Mullish BH; Williams HR
Clin Med (Lond); 2018 Jun; 18(3):237-241. PubMed ID: 29858434
[TBL] [Abstract][Full Text] [Related]
20. Role of microbiota and innate immunity in recurrent Clostridium difficile infection.
Bibbò S; Lopetuso LR; Ianiro G; Di Rienzo T; Gasbarrini A; Cammarota G
J Immunol Res; 2014; 2014():462740. PubMed ID: 24995345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
